KMPHARMACEUTICALLtd's earnings have been declining at an average annual rate of -35.6%, while the Personal Products industry saw earnings growing at 23.8% annually. Revenues have been declining at an average rate of 9.1% per year.
How KMPHARMACEUTICALLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A225430 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
16,379
-3,978
6,202
899
31 Dec 25
15,990
-3,968
5,975
944
30 Sep 25
15,093
-4,678
6,044
837
30 Jun 25
14,015
-4,612
5,802
719
31 Mar 25
14,088
-4,881
6,407
628
31 Dec 24
14,475
-4,573
6,392
560
30 Sep 24
14,545
-3,648
6,072
478
30 Jun 24
15,295
-3,208
6,051
397
31 Mar 24
17,095
-1,817
5,391
337
31 Dec 23
17,770
-1,320
5,230
298
30 Sep 23
17,580
-2,776
6,871
321
30 Jun 23
17,711
-3,266
6,434
376
31 Mar 23
16,044
-3,905
6,055
414
31 Dec 22
15,631
-3,925
5,996
450
30 Sep 22
18,805
-1,864
3,917
492
30 Jun 22
20,000
-1,271
3,987
473
31 Mar 22
22,043
-670
4,252
445
31 Dec 21
22,705
-611
4,014
405
30 Sep 21
21,335
-229
3,561
320
30 Jun 21
21,164
-15
3,789
277
31 Mar 21
22,518
73
4,016
272
31 Dec 20
22,928
471
4,371
307
30 Sep 20
22,844
-512
5,826
371
30 Jun 20
23,443
-552
6,625
304
31 Mar 20
21,326
-612
6,349
421
31 Dec 19
20,338
-902
6,534
368
30 Sep 19
19,731
233
5,647
291
30 Jun 19
18,406
-12,319
4,489
291
31 Mar 19
17,477
-12,561
4,537
158
31 Dec 18
17,302
-12,330
3,810
178
30 Sep 18
16,654
-12,004
3,264
161
31 Dec 17
16,915
1,752
3,173
100
Quality Earnings: A225430 is currently unprofitable.
Growing Profit Margin: A225430 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A225430 is unprofitable, and losses have increased over the past 5 years at a rate of 35.6% per year.
Accelerating Growth: Unable to compare A225430's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A225430 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (10.8%).
Return on Equity
High ROE: A225430 has a negative Return on Equity (-14.5%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/04 17:33
End of Day Share Price
2026/06/04 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
KMPHARMACEUTICAL Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.